A fun article to think about compositional effects:

https://www.sciencedirect.com/science/article/pii/S0002916523036626

My own experience is here:

https://journals.lww.com/aidsonline/Fulltext/2010/09100/Associations_of_antiretroviral_drug_use_and.8.aspx

Abacavir and tenofovir are both drugs used in HAART, but usually one or the other. I found a protective association of tenofovir with subclinical CVD when probably it was the complement of an adverse Abacavir association with subclinical CVD.

Tricky area.

Associations of antiretroviral drug use and HIV-specific... : AIDS

r increased cIMT. Methods: We evaluated the relationship between HIV-related characteristics (including markers of HIV disease severity and use of antiretroviral therapy) and cIMT measurements in the internal/bulb and common carotid regions among 538 HIV-infected participants from the Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM). We used Bayesian model averaging to estimate the posterior probability of candidate HIV and non-HIV-related risk factors being true predictors of increased cIMT. Variables with a posterior probability of more than 50% were used to develop a selected regression model for each of the anatomic regions. Results: For common cIMT, the Bayesian model selection process identified age, African-American race, and systolic and diastolic blood pressure with probability more than 95%, HDL cholesterol with probability 85% and Hispanic ethnicity with probability 51%. Among the HIV-related factors included in the analysis, only tenofovir use was selected (51% probability). In the selected model, duration of tenofovir use was associated with lower common cIMT (−0.0094 mm/year of use; 95% confidence interval: −0.0177 to −0.0010). For internal cIMT, no HIV-related risk factors were above the 50% posterior probability threshold. Conclusion: We observed an inverse association between duration of tenofovir use and common carotid cIMT. Whether this association is causal or due to confounding by indication needs further investigation....

LWW